BHG Executive and Leadership Team

Paul Di Vincenzo, the Chief Technology Officer at BHG, directs the strategic implementation and oversight of all technology initiatives. This leadership role involves architecting scalable and secure IT infrastructure to support BHG's extensive network of outpatient opioid treatment and recovery centers across the United States. Di Vincenzo ensures that technological advancements directly enhance the delivery of comprehensive, personalized evidence-based medical and behavioral therapies for individuals with opioid use disorder (OUD). By optimizing data management and digital platforms, the Chief Technology Officer facilitates seamless operations and improves patient access to care. Paul Di Vincenzo's focus remains on leveraging innovation to strengthen BHG's position as the largest network of Joint Commission-accredited centers, driving efficiency and effectiveness in patient recovery programs nationwide. This involves managing cybersecurity protocols and exploring emerging technologies that can further personalize treatment pathways and support long-term patient outcomes.

Charles Panicker, the Chief Revenue Officer at BHG, spearheads all revenue generation strategies and commercial operations. This executive function encompasses driving growth across BHG's network of Joint Commission-accredited outpatient opioid treatment and recovery centers. Panicker focuses on expanding market reach and optimizing revenue streams by ensuring the effective delivery of comprehensive, personalized evidence-based medical and behavioral therapies for individuals with opioid use disorder (OUD). The Chief Revenue Officer collaborates closely with clinical and operational leadership to align financial objectives with patient care goals, ensuring sustainable expansion of services. Charles Panicker's leadership is critical in developing and executing commercial strategies that support BHG's mission to provide accessible and effective recovery solutions nationwide. This involves analyzing market trends, identifying new partnership opportunities, and enhancing the value proposition for patients and stakeholders, ultimately contributing to the organization's financial health and its capacity to serve more individuals battling opioid use disorder.

Benjamin Nordstrom, the Chief Medical Officer at BHG, provides critical medical leadership and strategic direction for all clinical operations. This role ensures the highest standards of care are maintained across BHG's network of Joint Commission-accredited outpatient opioid treatment and recovery centers. Nordstrom oversees the implementation and continuous improvement of evidence-based medical and behavioral therapies for individuals with opioid use disorder (OUD), ensuring treatment protocols are current and effective. The Chief Medical Officer plays a pivotal part in shaping BHG's clinical philosophy, focusing on patient-centered approaches and optimal recovery outcomes. Benjamin Nordstrom's expertise guides the integration of medical advancements and best practices into daily patient care, reinforcing BHG's commitment to being the leading provider of OUD treatment in the United States. This involves rigorous quality assurance, clinical research initiatives, and fostering a culture of clinical excellence among healthcare professionals.

Russell Goin, the Chief People Officer at BHG, directs all human resources functions and organizational development strategies. This executive leadership ensures BHG cultivates a high-performing workforce dedicated to delivering exceptional care across its network of Joint Commission-accredited outpatient opioid treatment and recovery centers. Goin focuses on attracting, retaining, and developing top talent essential for providing comprehensive, personalized evidence-based medical and behavioral therapies for individuals with opioid use disorder (OUD). The Chief People Officer champions BHG's culture, fostering an environment that supports employee well-being and professional growth, which is crucial for sustained operational excellence. Russell Goin's strategic initiatives are vital in aligning human capital with BHG's mission to be the premier provider of OUD treatment, ensuring that every team member is equipped to contribute to patient recovery and organizational success nationwide.